Management of scoliosis

Does Your Child Have Scoliosis?

Retrieved on: 
Tuesday, June 1, 2021

This year we decided to focus on what to expect if your child is diagnosed with scoliosis.

Key Points: 
  • This year we decided to focus on what to expect if your child is diagnosed with scoliosis.
  • It is important to understand that "watch and wait" does not equal doing nothing at all.
  • A clinician will closely monitor your child through X-rays and visits to determine if the curve progresses and further treatment is needed.
  • Luke Stikeleather, President and Founder of National Scoliosis Center says, "Early detection can mean the difference between a child wearing a brace versus a child needing spinal fusion surgery."

VNTC Develops the World's First Hybrid Scoliosis Brace - Spinamic

Retrieved on: 
Wednesday, May 5, 2021

b'From a rigid to hybrid brace, Spinamic setting a new trendfor scoliosis bracing\nSEOUL, South Korea, May 5, 2021 /PRNewswire/ -- VNTC, a MedTech company, has developed Spinamic, the world\'s first vest-like wearable hybrid scoliosis brace, which combines the benefits of both conventional rigid and soft- type scoliosis braces.

Key Points: 
  • b'From a rigid to hybrid brace, Spinamic setting a new trendfor scoliosis bracing\nSEOUL, South Korea, May 5, 2021 /PRNewswire/ -- VNTC, a MedTech company, has developed Spinamic, the world\'s first vest-like wearable hybrid scoliosis brace, which combines the benefits of both conventional rigid and soft- type scoliosis braces.
  • Scoliosis is a disease that develops into mild, moderate, and severe state over a long period.
  • Proactive treatment for scoliosis is necessary to avoid a possible surgery that might leave scars and side effects in the future.\nIn particular, girls account for 84% of all teenagers with scoliosis.
  • During the fitting process of conventional brace, physical contact is unavoidable and can cause them to feel embarrassed.

OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal Deformity Correction System for Treating AIS

Retrieved on: 
Thursday, February 18, 2021

The new website includes actionable information and convenient links to help anyone understand more about AIS and the potential benefits of the ApiFix procedure.

Key Points: 
  • The new website includes actionable information and convenient links to help anyone understand more about AIS and the potential benefits of the ApiFix procedure.
  • The ApiFixprocedure offers select AIS patients a less invasive, motion-preserving option for achieving curve correction without the permanence of fusion.
  • The ApiFix procedure is a viable treatment alternative to failed bracing, potentially allowing patients to avoid the permanence of spinal fusion surgery.
  • ApiFix, a leader in motion-preserving scoliosis correction, was acquired by OrthoPediatrics in April 2020 and operates as a wholly-owned subsidiary based in Israel.

Siblings and Scoliosis: The Genetic Correlation

Retrieved on: 
Tuesday, February 9, 2021

Although the specific causes are unknown, scientific studies and history reveal that the condition tends to be familial, with a definite genetic component.

Key Points: 
  • Although the specific causes are unknown, scientific studies and history reveal that the condition tends to be familial, with a definite genetic component.
  • Idiopathic scoliosis is particularly well suited for genetic study since it is most frequently discovered in childhood.
  • Some of the most exciting research, however, points to the genetic connection in particular aspects of curvature, especially curve severity (Wise, 2008).
  • Understanding research on these specific genetic correlations will greatly benefit families with a history of scoliosis.

OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology

Retrieved on: 
Wednesday, April 1, 2020

Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, We believe that ApiFix fills a major treatment gap that could potentially allow patients to avoid fusion surgery.

Key Points: 
  • Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, We believe that ApiFix fills a major treatment gap that could potentially allow patients to avoid fusion surgery.
  • The acquisition of this novel technology keeps OrthoPediatrics at the forefront of pediatric orthopedic care with a viable alternative to failed bracing and spinal fusion for the treatment of progressive scoliosis.
  • We are also pleased to announce a major acquisition at this time which significantly enhances our long-term strategic position.
  • ApiFix is a leading motion-preservation scoliosis correction company developing a unique platform technology that represents a disruptive approach to spine deformity treatment.

EOS Images and 3D Models Supporting More Than 35 Podium Presentations and Scientific Posters at Scoliosis Research Society (SRS) 54th Annual Meeting

Retrieved on: 
Tuesday, September 17, 2019

The number of presentations highlights the importance of EOS in the management of scoliosis, assessment of sagittal alignment and surgical planning.

Key Points: 
  • The number of presentations highlights the importance of EOS in the management of scoliosis, assessment of sagittal alignment and surgical planning.
  • Since 2014, EOS imaging has collaborated with the Harms Study Group (HSG), a leading research group for scoliosis, to provide access to 3D models for its research.
  • At SRS this year, HSG members will present numerous podium and poster presentations leveraging EOS images or 3D models, demonstrating the value of EOS in the analysis of adolescent idiopathic scoliosis.
  • This collaboration has allowed the Harms Study Group to produce more than 20 annual scientific presentations and seven peer-reviewed publications to date.

ApiFix Receives FDA Approval to Commercialize MID-C System for Motion-Preserving Deformity Treatment of Progressive Idiopathic Scoliosis in Adolescents

Retrieved on: 
Tuesday, August 27, 2019

ApiFix Ltd., a leading motion-preservation scoliosis correction company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) via a Humanitarian Device Exemption (HDE) to market the Minimally Invasive Deformity Correction (MID-C) system for the treatment of progressive adolescent idiopathic scoliosis (AIS).

Key Points: 
  • ApiFix Ltd., a leading motion-preservation scoliosis correction company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) via a Humanitarian Device Exemption (HDE) to market the Minimally Invasive Deformity Correction (MID-C) system for the treatment of progressive adolescent idiopathic scoliosis (AIS).
  • FDA approval of ApiFixs MID-C system is a significant achievement for our company, said Paul Mraz, CEO for ApiFix Ltd.
  • But more importantly, it makes a notable treatment advancement available for patients and their families who want FDA approved alternatives to permanent spinal fusion.
  • ApiFix is a leading motion-preservation scoliosis correction company developing a unique platform technology that represents a disruptive approach to spine deformity treatment.

FDA approves first of its kind device to treat pediatric patients with progressive idiopathic scoliosis

Retrieved on: 
Friday, August 16, 2019

"For children and adolescent patients with idiopathic scoliosis that does not respond favorably to bracing, treatment options have been limited to fusion surgeries," said Capt.

Key Points: 
  • "For children and adolescent patients with idiopathic scoliosis that does not respond favorably to bracing, treatment options have been limited to fusion surgeries," said Capt.
  • "Today's approval provides access to a new treatment option that could improve quality of life for patients with idiopathic scoliosis."
  • Approximately 6,800 patients in the U.S. each year will develop progressive curvatures that do not respond to bracing.
  • The Tether Vertebral Body Tethering System provides an alternative for patients with idiopathic scoliosis that doesn't respond to bracing.